130 related articles for article (PubMed ID: 10869748)
1. The role of low-dose total body irradiation in treatment of non-Hodgkin's lymphoma: a new look at an old method.
Safwat A
Radiother Oncol; 2000 Jul; 56(1):1-8. PubMed ID: 10869748
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor effects by low dose total body irradiation].
Hosoi Y
Yakugaku Zasshi; 2006 Oct; 126(10):841-8. PubMed ID: 17016015
[TBL] [Abstract][Full Text] [Related]
3. Low-dose total body irradiation in non-Hodgkin lymphoma: short- and long-term toxicity and prognostic factor.
De Neve WJ; Lybeert ML; Meerwaldt JH
Am J Clin Oncol; 1990 Aug; 13(4):280-4. PubMed ID: 2198791
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of low dose total body irradiation for advanced non-Hodgkin lymphoma.
Lybeert ML; Meerwaldt JH; Deneve W
Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1167-72. PubMed ID: 3301759
[TBL] [Abstract][Full Text] [Related]
5. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.
Travis LB; Weeks J; Curtis RE; Chaffey JT; Stovall M; Banks PM; Boice JD
J Clin Oncol; 1996 Feb; 14(2):565-71. PubMed ID: 8636772
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.
Song DY; Jones RJ; Welsh JS; Haulk TL; Korman LT; Noga S; Goodman S; Herman M; Mann R; Marcellus D; Vogelsang G; Ambinder RF; Abrams RA
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):166-71. PubMed ID: 12909229
[TBL] [Abstract][Full Text] [Related]
7. The potential palliative role and possible immune modulatory effects of low-dose total body irradiation in relapsed or chemo-resistant non-Hodgkin's lymphoma.
Safwat A; Bayoumy Y; El-Sharkawy N; Shaaban K; Mansour O; Kamel A
Radiother Oncol; 2003 Oct; 69(1):33-6. PubMed ID: 14597354
[TBL] [Abstract][Full Text] [Related]
8. A phase I study of WR-2721 in combination with total body irradiation (TBI) in patients with refractory lymphoid malignancies.
Coia L; Krigel R; Hanks G; Comis R; Algazy K; Peters R; McCulloch W; Schien P
Int J Radiat Oncol Biol Phys; 1992; 22(4):791-4. PubMed ID: 1312076
[TBL] [Abstract][Full Text] [Related]
9. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
[TBL] [Abstract][Full Text] [Related]
10. The immunobiology of low-dose total-body irradiation: more questions than answers.
Safwat A
Radiat Res; 2000 May; 153(5 Pt 1):599-604. PubMed ID: 10790282
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of total body irradiation in chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphomas.
Roncadin M; Arcicasa M; Bortolus R; Trovó MG; Carbone A; Tirelli U; De Paoli A; Franchin G; Grigoletto E
Cancer Invest; 1991; 9(4):403-7. PubMed ID: 1884246
[TBL] [Abstract][Full Text] [Related]
12. Total body irradiation and prednimustine in chronic lymphocytic leukemia and low grade non-Hodgkin's lymphomas. A 9-year experience at a single institution.
Roncadin M; Arcicasa M; Zagonel V; Bortolus R; Valeri P; Pinto A; De Paoli A; Franchin G; Carbone A; Trovò MG
Cancer; 1994 Aug; 74(3):978-84. PubMed ID: 8039128
[TBL] [Abstract][Full Text] [Related]
13. Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
Specht L
Curr Treat Options Oncol; 2016 Jan; 17(1):4. PubMed ID: 26739151
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
16. Dose-escalated total body irradiation and autologous stem cell transplantation for refractory hematologic malignancy.
McAfee SL; Powell SN; Colby C; Spitzer TR
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):151-6. PubMed ID: 12007954
[TBL] [Abstract][Full Text] [Related]
17. High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.
Schiffman K; Buckner CD; Maziarz R; Maloney DG; Appelbaum FR; Press O; Gooley T; Holmberg L; Lilleby K; Clift R; Zuckerman N; Klarnet J; Weaver C; Chauncey T; Bensinger WI
Biol Blood Marrow Transplant; 1997 Nov; 3(5):261-6. PubMed ID: 9450921
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial.
Demirer T; Petersen FB; Appelbaum FR; Barnett TA; Sanders J; Deeg HJ; Storb R; Doney K; Bensinger WI; Shannon-Dorcy K
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1103-9. PubMed ID: 7607931
[TBL] [Abstract][Full Text] [Related]
19. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
Hoederath A; Sack H; Stuschke M; Lampka E
Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402
[TBL] [Abstract][Full Text] [Related]
20. The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
Laport GF; Williams SF
Semin Oncol; 1998 Aug; 25(4):503-17. PubMed ID: 9728600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
